Explained: Why Moderna’s Covid-19 vaccine scores over Pfizer’s jab and why it could be a compelling option for India

US biotech company Moderna on Monday announced that the first interim analysis of its Covid-19 vaccine demonstrated 94.5 percent efficacy. Moderna said the trial has met the statistical criteria pre-… [read more]

Leave a Comment